Ofotokun, I., Collins, L. F., Titanji, K., Foster, A., Moran, C. A., Sheth, A. N., . . . Weitzmann, M. N. (2019). Antiretroviral Therapy–Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB Trial. Clin Infect Dis.
Style de citation ChicagoOfotokun, Ighovwerha, et al. "Antiretroviral Therapy–Induced Bone Loss Is Durably Suppressed By a Single Dose of Zoledronic Acid in Treatment-Naive Persons With Human Immunodeficiency Virus Infection: A Phase IIB Trial." Clin Infect Dis 2019.
Style de citation MLAOfotokun, Ighovwerha, et al. "Antiretroviral Therapy–Induced Bone Loss Is Durably Suppressed By a Single Dose of Zoledronic Acid in Treatment-Naive Persons With Human Immunodeficiency Virus Infection: A Phase IIB Trial." Clin Infect Dis 2019.